What move does the options market price into Ironwood Pharmaceuticals's report?

Implied ±15.4%, either direction.

How often does Ironwood Pharmaceuticals move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

IRWDNasdaqPharmaceutical Preparations

Ironwood Pharmaceuticals Inc (IRWD) earnings date, market-implied expected move, and options open interest by expiry

3.51

Pre-market16:00 ETdelayed

Open3.41Volume1.3MMkt cap$571.7MP/E4.44EPS0.79

Day3.41 – 3.5476%52-wk1.76 – 5.7844%

IRWD

Ironwood Pharmaceuticals Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±15.4%implied · report alone

8Q avg ±13.9%·×1.11·fair

2.964.04

straddle ±25.5%

spot 3.50exp Nov 20ATM strike 2.5ATM straddle 1.05IV 103%

Nov 3 closereport share · term structure

Expected move

Inputs

Next report

Nov 9

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

+2.65%

vs ±15.6% implied · ×0.17

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

17hABBV · supplierAbbVie posts net earnings $4,220 million, diluted EPS $2.37 for quarter
1dAZN · customerAstraZeneca admits 11,948 ordinary shares to London Main Market

News

Largest filed tie

13F top-10 QoQ

+2.44%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

212 managers

Top fund weight

0.22%

IRWD weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Ironwood Pharmaceuticals (IRWD) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±30.8%
avg realized: ±13.9%

Apr 25 '25Apr 25 '25confirmed±57.8%▲+1.12%×0.02

May 7 '25May 7 '25confirmed±47.7%▼−14.55%×0.31

Aug 7 '25Aug 7 '25confirmed±35.6%▲+9.32%×0.26

Q3 FY25Nov 10 '25confirmed±27.6%▲+31.77%×1.15

Jan 2 '26Jan 2 '26confirmed±28.3%▲+26.71%×0.94

Q1 FY26Feb 25 '26confirmed±22.4%▼−11.35%×0.51

May 7 '26May 7 '26confirmed±11.8%▼−13.66%×1.16

Q2 FY26Aug 6 '26confirmed±15.6%▲+2.65%×0.17

quarterimplied−60%0+60%realized×

Q2 FY26±15.6%▲+2.65%×0.17

May '26±11.8%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Oct 23 close

0.57OI · 2 expiries · Oct 23 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2,3400%Nov 2016d4,074+2%

128+8%Feb 19107d0.062,027+1%0.06

ExpiryPutsCallsP/C

Nov 2016d2,3400%4,074+2%0.57

Feb 19107d128+8%2,027+1%0.06

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±25.5%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

45.37%as filednet margin · revenue +6.14% QoQ · +32.62% YoY

Revenue

$113M+6.14% QoQ

Gross profit

$113M+6.14% QoQ

100.00% margin

Operating income

$79M+9.28% QoQ

70.16% margin

Pre-tax income

$74M+13.13% QoQ

Net income

$51M+25.80% QoQ

45.37% margin

Operating expenses

$34M−0.59% QoQ

R&D $22M

SG&A $11M

Other expense

$6M

Tax

$22M−8.03% QoQ

Revenue$113M+6.14%

Gross profit

$113M+6.14%

100.00% margin

Operating income

$79M+9.28%

70.16% margin

Pre-tax income

$74M+13.13%

Net income

$51M+25.80%

45.37% margin

Cost of revenue

Operating expenses

$34M−0.59%

R&D $22M

SG&A $11M

Other expense

$6M

Tax$22M−8.03%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ down · bars = volume, 15mSource: market data · 16:00 ET

Intraday

Event sensitivity

GDP ×1.46· ±5.6% vs ±3.8% · 19 releases

eventrelease day|move|up · n×base

GDPgross domestic product±5.6%5 of 19×1.46

PPIproducer prices±4.9%4 of 10×1.28

FOMCrate decision±4.0%11 of 24×1.05

PCEpersonal income & outlays±4.0%4 of 19×1.03

CPROFcorporate profits±3.2%5 of 12×0.84

CPIconsumer prices±2.5%5 of 10×0.66

NFPjobs report±2.4%4 of 10×0.63

Bar = avg |move| to ±6% · tick = ±3.8% avg day · ×base = |move| ÷ ±3.8% · min 6 releases

Earnings history

EPS 0.31 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	0.31	—
Q1 FY26	Feb 25 '26 · confirmed	0.24	—
Q3 FY25	Nov 10 '25 · confirmed	0.23	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod